Focusing on the right things can get rewarding. With this belief, a leading hyperuricemia therapy brand decided to segment
An ophthalmic brand launched itself one month prior to the global COVID-19 pandemic.
Hugely cluttered market of pain management drugs with low-differentiation, and even lower Physician involvement.
